SRC and systemic sclerosis: We recently reported that protein tyrosine phosphatase 4A type 1 (PTP4A1) is overexpressed in dermal fibroblasts and myofibroblasts from patients with SSc, and it supports sustained TGF-β signaling by enhancing SRC activity (15).